購読する
モデル製品
サービス
前臨床薬効評価
コミュ二ティー
B6RG Mouse
製品のお見積りを依頼する
当社のカタログから製品を選択してご注文ください。当社チームが詳細な情報をご連絡いたします。
B6RG Mouse
製品名
B6RG Mouse
製品ID
C001367
系統名
C57BL/6JCya-Rag2em1Il2rgem1/Cya
背景情報
C57BL/6JCya
状況
このマウス系統を論文で使用する場合は、「B6RG Mouse(カタログ番号C001367)はサイアジェンから購入しました。」と引用してください。
Other Immunodeficient Mice
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
お見積もりについてはこちらまでご連絡ください
Other Immunodeficient Mice
基本情報
検証 Data
関連リソース
基本情報
遺伝子別名
gc, p64, [g]c, CD132, gamma(c), Rag-2
染色体
Chr X, Chr 2
さらに
系統詳細
The IL2RG gene, also known as the CD132 gene, encodes the interleukin-2 receptor gamma chain (IL-2Rγ), an essential signaling component of many interleukin receptors, and a common receptor subunit for various key immune factors, including IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. These interleukin receptors are located on the surface of immune cells. When an interleukin binds to its receptor, it triggers a series of chemical reactions within the cell, promoting cell growth and division; thus, the IL-2 receptor gamma chain is also called the common gamma chain (γc). Mutations in IL2RG in humans can lead to X-linked severe combined immunodeficiency (X-SCID), characterized by a lack of T cells and natural killer cells and impaired B cell function, making patients highly susceptible to recurrent infections and typically not surviving past infancy [1-2]. In mice, knockout of the Il2rg gene results in severe deficiencies of B cells, T cells, and NK cells in bone marrow, peripheral blood, and spleen, displaying a severe immunodeficient phenotype [2].
The RAG2 gene encodes a protein that, together with the RAG1 protein, forms the RAG complex, playing a crucial role in V(D)J recombination during the maturation of B and T cells. During V(D)J recombination, the RAG complex attaches to the recombination signal sequences (RSS) located adjacent to V, D, or J segments in the DNA. The RAG complex cuts the DNA between the signal sequences and the segments, allowing the segments to separate and move to different regions of the genome. This process occurs repeatedly in B and T cells, arranging the V, D, and J segments in various combinations. The resulting protein diversity provides a broader capability to recognize foreign invaders, allowing the body to combat infections effectively. RAG2 is essential in V(D)J recombination, not only catalyzing the reaction but also regulating it by controlling access to specific loci [3]. A lack of functional RAG2 protein can also lead to severe combined immunodeficiency (SCID). In mice, deleting the Rag2 gene results in the absence of V(D)J recombination, blocking the differentiation, development, and maturation of T and B cells, which lose their normal functions, leading to a SCID-like phenotype [4].
The B6RG mouse is a double gene knockout model of Rag2 and IL2rg on the C57BL/6 background. Homozygous B6RG mice develop normally and are fertile but do not produce mature T cells, B cells, or NK cells. They can be used in studies related to immune system deficiencies, cancer, toxicology, and xenotransplantation.
参考文献
Spolski R, Li P, Leonard WJ. Biology and regulation of IL-2: from molecular mechanisms to human therapy. Nat Rev Immunol. 2018 Oct;18(10):648-659.
Cao X, Shores EW, Hu-Li J, Anver MR, Kelsall BL, Russell SM, Drago J, Noguchi M, Grinberg A, Bloom ET, et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity. 1995 Mar;2(3):223-38.
Schatz DG. V(D)J recombination. Immunol Rev. 2004 Aug;200:5-11.
Hao Z, Rajewsky K. Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J Exp Med. 2001 Oct 15;194(8):1151-64.
系統作製戦略
Rag2 is located on chromosome 2 in mice, and exon 3 of the Rag2 gene was knocked out using gene editing technology. Il2rg is located on the X chromosome in mice, and exons 2-6 of the Il2rg gene were knocked out using gene editing technology. The two types of mice were then crossbred to obtain the B6RG double gene knockout mouse model.

Figure 1.Rag2 gene targeting program.

Figure 2. Il2rg gene targeting program.
適用分野
Research on immune system defects;
Research on cancer and xenotransplantation, etc.;
Toxicology research.
検証 Data
1. Flow cytometry detection of T, B, and NK cells in peripheral blood, spleen, and bone marrow
Peripheral blood (PB), spleen, and bone marrow (BM) from wild-type and B6RG mice were subjected to representative flow cytometry immunophenotyping analysis and statistical comparison of their T, B, and NK cell composition. The results indicate that, compared to wild-type mice, B6RG mice show an almost complete absence of B cells (CD3-CD19+), T cells (CD3+CD19-), and NK cells (CD335+CD3-) in peripheral blood, spleen, and bone marrow.

Figure 3. Flow cytometry results of B, T, and NK cells in wild-type (WT) and B6RG mice.
2. Flow cytometry detection of myeloid cells in peripheral blood, spleen, and bone marrow
(1)Detection of monocytes, macrophages, neutrophils, and dendritic cells (DC) in peripheral blood
The results show that compared to wild-type mice, B6RG mice have a significant increase in Lin- cells (excluding T, B, and NK cells) in peripheral blood. There is no significant difference in the proportions of macrophages and dendritic cells (DC), a slight increase in the proportion of monocytes, and a significant increase in the proportion of neutrophils.

Figure 4. Flow cytometry results of myeloid cells in the peripheral blood of 6-week-old female wild-type (WT) and B6RG mice (n=3).
(2)Detection of monocytes, macrophages, neutrophils, and dendritic cells (DC) in the spleen
The results show a significant increase in Lin- cells (excluding T, B, and NK cells) in the spleens of B6RG mice compared to wild-type mice. There is no significant difference in the proportions of monocytes, macrophages, and dendritic cells (DC), but a notable increase in the proportion of neutrophils.

Figure 5. Flow cytometry results of myeloid cells in the spleens of 6-week-old female wild-type (WT) and B6RG mice (n=3).
(3)Detection of monocytes, macrophages, neutrophils, and dendritic cells (DC) in bone marrow
The results show a significant increase in Lin- cells (excluding T, B, and NK cells) in the bone marrow of B6RG mice compared to wild-type mice. There is no significant difference in the proportions of monocytes, macrophages, and dendritic cells (DC), but a slight increase in the proportion of neutrophils.

Figure 6. Flow cytometry results of myeloid cells in the bone marrow of 6-week-old female wild-type (WT) and B6RG mice (n=3).
3. CDX (Cell Line-Derived Xenograft) Model Establishment
(1)Case 1
6-week-old female B6RG mice were selected, and the tumor model was established via subcutaneous inoculation of AsPC-1 tumor cells. After modeling, tumor growth (left panel) and body weight changes of mice (right panel) were continuously monitored and recorded at different time points. The results showed that the subcutaneous inoculation of AsPC-1 cells in B6RG mice could effectively establish a stable tumor model. (Data are presented as Mean ± SD, n=3)

Figure 7. Subcutaneous Xenograft Tumor Model Establishment of AsPC-1 Cells in B6RG Mice.
*This data was provided by Cyagen's partners.
(2)Case 2
After subcutaneous inoculation of HepG2 cells into B6RG mice, the changes in tumor volume (left panel) and mouse body weight (right panel) were monitored at different time points. The results showed that HepG2 cells could stably form tumors subcutaneously in B6RG mice, indicating that this strain is suitable for establishing HepG2 subcutaneous xenograft tumor models. (Data are expressed as Mean ± SD)

Figure 8. Tumorigenicity Evaluation of HepG2 Cells in B6RG Mice (7 weeks old, female, n=5).
*This data was provided by Cyagen's partners.
関連リソース
お問い合わせ
ご不明な点やご質問などございましたら、お気軽にお問い合わせください。担当スタッフがサポートさせていただきます。下記のフォームにご記入いただければ、1〜2営業日以内に折り返しご連絡いたします。
Related Product
All Related Productsお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
